Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy (ERAS_Breast)

Monica Harbell

Status: Completed

Conditions: Breast Cancer Female; Mastectomy

Treatments: Other: ERAS pathway for Total Mastectomy

Study type: Observational

Funder types: Other

Identifiers

NCT03181139

ERASBreast

Details and patient eligibility

About

Retrospective analysis of pre and post-Enhanced Recovery after Surgery for Total mastectomy pathway implementation.

Full description

Retrospective analysis of pre- and post-Enhanced Recovery after surgery for total mastectomy pathway implementation in patients at Mount Zion Hospital. We examined perioperative opioid consumption, pain scores, post-operative nausea and vomiting, benzodiazepine use, length of stay for the time period before and after implementation of an Enhanced Recovery after Surgery pathway for Total mastectomy. Pathway features included preoperative acetaminophen and gabapentin, minimizing opioids, postoperative NSAIDs, Pecs blocks, and aggressive postoperative nausea and vomiting prophylaxis.

Enrollment: 386 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female patients at least 18 years old undergoing total skin sparing mastectomy at University of California San Francisco Mount Zion hospital

Exclusion criteria

• patients undergoing concurrent bilateral salpingo-oophorectomy, flap reconstruction

Trial design

386 participants in 2 patient groups

pre-ERAS

Description:

Patients cared for prior to the implementation of the Enhanced Recovery after surgery for total mastectomy pathway

post-ERAS

Description:

patients cared for after the implementation of the Enhanced Recovery after surgery for total mastectomy pathway. Pathway included preoperative acetaminophen and gabapentin, Pec blocks, multimodal analgesia postoperatively and aggressive PONV treatment.

Treatment:

Other: ERAS pathway for Total Mastectomy